CVAC
Price
$5.47
Change
+$0.03 (+0.55%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
1.23B
19 days until earnings call
MRNA
Price
$34.14
Change
+$0.13 (+0.38%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
13.21B
6 days until earnings call
Interact to see
Advertisement

CVAC vs MRNA

Header iconCVAC vs MRNA Comparison
Open Charts CVAC vs MRNABanner chart's image
CureVac
Price$5.47
Change+$0.03 (+0.55%)
Volume$3.17K
Capitalization1.23B
Moderna
Price$34.14
Change+$0.13 (+0.38%)
Volume$62.05K
Capitalization13.21B
CVAC vs MRNA Comparison Chart in %
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. MRNA commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a StrongBuy and MRNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CVAC: $5.46 vs. MRNA: $34.15)
Brand notoriety: CVAC: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 39% vs. MRNA: 53%
Market capitalization -- CVAC: $1.23B vs. MRNA: $13.21B
CVAC [@Biotechnology] is valued at $1.23B. MRNA’s [@Biotechnology] market capitalization is $13.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 4 TA indicator(s) are bullish while MRNA’s TA Score has 6 bullish TA indicator(s).

  • CVAC’s TA Score: 4 bullish, 4 bearish.
  • MRNA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а +1.30% price change this week, while MRNA (@Biotechnology) price change was +9.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CVAC is expected to report earnings on Nov 18, 2025.

MRNA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($13.2B) has a higher market cap than CVAC($1.23B). CVAC YTD gains are higher at: 60.117 vs. MRNA (-17.869). CVAC has higher annual earnings (EBITDA): 228M vs. MRNA (-3.2B). MRNA has more cash in the bank: 5.98B vs. CVAC (442M). CVAC has less debt than MRNA: CVAC (37.4M) vs MRNA (745M). MRNA has higher revenues than CVAC: MRNA (3.14B) vs CVAC (524M).
CVACMRNACVAC / MRNA
Capitalization1.23B13.2B9%
EBITDA228M-3.2B-7%
Gain YTD60.117-17.869-336%
P/E Ratio5.80N/A-
Revenue524M3.14B17%
Total Cash442M5.98B7%
Total Debt37.4M745M5%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACMRNA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RXL41.350.37
+0.91%
ProShares Ultra Health Care
VFMO176.800.81
+0.46%
Vanguard US Momentum Factor ETF
PSCT46.350.15
+0.32%
Invesco S&P SmallCap Info Tech ETF
FEAC26.63N/A
N/A
Fidelity Enhanced U.S. All-Cap Equity ETF
STAX25.41N/A
N/A
Macquarie Tax-Free USA Short Term ETF

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with AIM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+0.37%
AIM - CVAC
44%
Loosely correlated
-0.18%
BNTX - CVAC
41%
Loosely correlated
+0.65%
MRNA - CVAC
40%
Loosely correlated
+0.41%
ARCT - CVAC
39%
Loosely correlated
-0.07%
AXON - CVAC
39%
Loosely correlated
+3.63%
More